IAMERS SUPPORTS ITS MEMBERS IN MANY WAYS.
Networking, Education, Patient Safety and Advocacy. With declining provider revenues, stronger business practices and an industry in transition, you need to know information critical to your business. IAMERS is following what matters most to your business.
Our efforts are gaining recognition and momentum as the marketplace is recognizing the importance and cost effectiveness of the Independent Provider of services and devices. For many if these less expensive, but clinically relevant, options were not available then their patients would miss receiving the health care they need and deserve.
Take the time to learn about our efforts in the regulatory and legislative arenas.
FDA Remanufacturing Guidance Comment Period Extended
On June 24, 2021, the FDA released a draft version of the FDA Remanufacturing Guidance. At the request of industry, the time frame for providing written comments to the guidance [...]
Brexit agreement begins now: Are you ready?
By Robert J. Kerwin It was four years ago that Britain’s then-prime minister, David Cameron, set a referendum on the U.K.’s continued membership in the European Union. In June 2016, [...]
FDA adverse event reporting form to include question as to third-party service
By Robert J. Kerwin Medical device manufacturers, importers, distributors and user facilities have long been required to report deaths, serious injuries and malfunctions that have, may have or would be [...]